United States Neuromyelitis Optica Drug Market Report 2017

January 2017 | 112 pages | ID: U28070B340FEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Neuromyelitis Optica Drug

Revenue, means the sales value of Neuromyelitis Optica Drug

This report studies sales (consumption) of Neuromyelitis Optica Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer?
• Fresenius?
• TEVA?
• Sandoz?
• Intas
• Gyjtrs?
• Nang Kuang
• Tianjin Kingyork
• Baxter?
• CSL?
• Grifols?
• Octapharma?
• CBOP?

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Glucocorticoids
• Immunoglobulin
• Other

Split by applications, this report focuses on sales, market share and growth rate of Neuromyelitis Optica Drug in each application, can be divided into

• Acute attack
• Remission prophylactic treatment

Contents

United States Neuromyelitis Optica Drug Market Report 2017

1 NEUROMYELITIS OPTICA DRUG OVERVIEW

1.1 Product Overview and Scope of Neuromyelitis Optica Drug
1.2 Classification of Neuromyelitis Optica Drug
  1.2.1 Glucocorticoids
  1.2.2 Immunoglobulin
  1.2.3 Other
1.3 Application of Neuromyelitis Optica Drug
  1.3.1 Acute attack
  1.3.2 Remission prophylactic treatment
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Neuromyelitis Optica Drug (2011-2021)
  1.4.1 United States Neuromyelitis Optica Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Neuromyelitis Optica Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES NEUROMYELITIS OPTICA DRUG COMPETITION BY MANUFACTURERS

2.1 United States Neuromyelitis Optica Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Neuromyelitis Optica Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Neuromyelitis Optica Drug Average Price by Manufactures (2015 and 2016)
2.4 Neuromyelitis Optica Drug Market Competitive Situation and Trends
  2.4.1 Neuromyelitis Optica Drug Market Concentration Rate
  2.4.2 Neuromyelitis Optica Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NEUROMYELITIS OPTICA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Neuromyelitis Optica Drug Sales and Market Share by States (2011-2016)
3.2 United States Neuromyelitis Optica Drug Revenue and Market Share by States (2011-2016)
3.3 United States Neuromyelitis Optica Drug Price by States (2011-2016)

4 UNITED STATES NEUROMYELITIS OPTICA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Neuromyelitis Optica Drug Sales and Market Share by Type (2011-2016)
4.2 United States Neuromyelitis Optica Drug Revenue and Market Share by Type (2011-2016)
4.3 United States Neuromyelitis Optica Drug Price by Type (2011-2016)
4.4 United States Neuromyelitis Optica Drug Sales Growth Rate by Type (2011-2016)

5 UNITED STATES NEUROMYELITIS OPTICA DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Neuromyelitis Optica Drug Sales and Market Share by Application (2011-2016)
5.2 United States Neuromyelitis Optica Drug Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEUROMYELITIS OPTICA DRUG MANUFACTURERS PROFILES/ANALYSIS

6.1 Pfizer?
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.1.2.1 Glucocorticoids
    6.1.2.2 Immunoglobulin
  6.1.3 Pfizer? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Fresenius?
  6.2.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.2.2.1 Glucocorticoids
    6.2.2.2 Immunoglobulin
  6.2.3 Fresenius? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 TEVA?
  6.3.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.3.2.1 Glucocorticoids
    6.3.2.2 Immunoglobulin
  6.3.3 TEVA? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Sandoz?
  6.4.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.4.2.1 Glucocorticoids
    6.4.2.2 Immunoglobulin
  6.4.3 Sandoz? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Intas
  6.5.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.5.2.1 Glucocorticoids
    6.5.2.2 Immunoglobulin
  6.5.3 Intas Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Gyjtrs?
  6.6.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.6.2.1 Glucocorticoids
    6.6.2.2 Immunoglobulin
  6.6.3 Gyjtrs? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Nang Kuang
  6.7.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.7.2.1 Glucocorticoids
    6.7.2.2 Immunoglobulin
  6.7.3 Nang Kuang Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Tianjin Kingyork
  6.8.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.8.2.1 Glucocorticoids
    6.8.2.2 Immunoglobulin
  6.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Baxter?
  6.9.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.9.2.1 Glucocorticoids
    6.9.2.2 Immunoglobulin
  6.9.3 Baxter? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 CSL?
  6.10.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    6.10.2.1 Glucocorticoids
    6.10.2.2 Immunoglobulin
  6.10.3 CSL? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Grifols?
6.12 Octapharma?
6.13 CBOP?

7 NEUROMYELITIS OPTICA DRUG MANUFACTURING COST ANALYSIS

7.1 Neuromyelitis Optica Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neuromyelitis Optica Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neuromyelitis Optica Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neuromyelitis Optica Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEUROMYELITIS OPTICA DRUG MARKET FORECAST (2016-2021)

11.1 United States Neuromyelitis Optica Drug Sales, Revenue Forecast (2016-2021)
11.2 United States Neuromyelitis Optica Drug Sales Forecast by Type (2016-2021)
11.3 United States Neuromyelitis Optica Drug Sales Forecast by Application (2016-2021)
11.4 Neuromyelitis Optica Drug Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neuromyelitis Optica Drug
Table Classification of Neuromyelitis Optica Drug
Figure United States Sales Market Share of Neuromyelitis Optica Drug by Type in 2015
Figure Glucocorticoids Picture
Figure Immunoglobulin Picture
Figure Other Picture
Table Application of Neuromyelitis Optica Drug
Figure United States Sales Market Share of Neuromyelitis Optica Drug by Application in 2015
Figure Acute attack Examples
Figure Remission prophylactic treatment Examples
Figure United States Neuromyelitis Optica Drug Sales and Growth Rate (2011-2021)
Figure United States Neuromyelitis Optica Drug Revenue and Growth Rate (2011-2021)
Table United States Neuromyelitis Optica Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Neuromyelitis Optica Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Neuromyelitis Optica Drug Sales Share by Manufacturers
Figure 2016 Neuromyelitis Optica Drug Sales Share by Manufacturers
Table United States Neuromyelitis Optica Drug Revenue by Manufacturers (2015 and 2016)
Table United States Neuromyelitis Optica Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Neuromyelitis Optica Drug Revenue Share by Manufacturers
Table 2016 United States Neuromyelitis Optica Drug Revenue Share by Manufacturers
Table United States Market Neuromyelitis Optica Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Neuromyelitis Optica Drug Average Price of Key Manufacturers in 2015
Figure Neuromyelitis Optica Drug Market Share of Top 3 Manufacturers
Figure Neuromyelitis Optica Drug Market Share of Top 5 Manufacturers
Table United States Neuromyelitis Optica Drug Sales by States (2011-2016)
Table United States Neuromyelitis Optica Drug Sales Share by States (2011-2016)
Figure United States Neuromyelitis Optica Drug Sales Market Share by States in 2015
Table United States Neuromyelitis Optica Drug Revenue and Market Share by States (2011-2016)
Table United States Neuromyelitis Optica Drug Revenue Share by States (2011-2016)
Figure Revenue Market Share of Neuromyelitis Optica Drug by States (2011-2016)
Table United States Neuromyelitis Optica Drug Price by States (2011-2016)
Table United States Neuromyelitis Optica Drug Sales by Type (2011-2016)
Table United States Neuromyelitis Optica Drug Sales Share by Type (2011-2016)
Figure United States Neuromyelitis Optica Drug Sales Market Share by Type in 2015
Table United States Neuromyelitis Optica Drug Revenue and Market Share by Type (2011-2016)
Table United States Neuromyelitis Optica Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neuromyelitis Optica Drug by Type (2011-2016)
Table United States Neuromyelitis Optica Drug Price by Type (2011-2016)
Figure United States Neuromyelitis Optica Drug Sales Growth Rate by Type (2011-2016)
Table United States Neuromyelitis Optica Drug Sales by Application (2011-2016)
Table United States Neuromyelitis Optica Drug Sales Market Share by Application (2011-2016)
Figure United States Neuromyelitis Optica Drug Sales Market Share by Application in 2015
Table United States Neuromyelitis Optica Drug Sales Growth Rate by Application (2011-2016)
Figure United States Neuromyelitis Optica Drug Sales Growth Rate by Application (2011-2016)
Table Pfizer? Basic Information List
Table Pfizer? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer? Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table Fresenius? Basic Information List
Table Fresenius? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fresenius? Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table TEVA? Basic Information List
Table TEVA? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table TEVA? Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table Sandoz? Basic Information List
Table Sandoz? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz? Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table Intas Basic Information List
Table Intas Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table Gyjtrs? Basic Information List
Table Gyjtrs? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gyjtrs? Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table Nang Kuang Basic Information List
Table Nang Kuang Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nang Kuang Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table Tianjin Kingyork Basic Information List
Table Tianjin Kingyork Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tianjin Kingyork Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table Baxter? Basic Information List
Table Baxter? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter? Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table CSL? Basic Information List
Table CSL? Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL? Neuromyelitis Optica Drug Sales Market Share (2011-2016)
Table Grifols? Basic Information List
Table Octapharma? Basic Information List
Table CBOP? Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromyelitis Optica Drug
Figure Manufacturing Process Analysis of Neuromyelitis Optica Drug
Figure Neuromyelitis Optica Drug Industrial Chain Analysis
Table Raw Materials Sources of Neuromyelitis Optica Drug Major Manufacturers in 2015
Table Major Buyers of Neuromyelitis Optica Drug
Table Distributors/Traders List
Figure United States Neuromyelitis Optica Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Neuromyelitis Optica Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Neuromyelitis Optica Drug Production Forecast by Type (2016-2021)
Table United States Neuromyelitis Optica Drug Consumption Forecast by Application (2016-2021)
Table United States Neuromyelitis Optica Drug Sales Forecast by States (2016-2021)
Table United States Neuromyelitis Optica Drug Sales Share Forecast by States (2016-2021)